CHICAGO, March 03, 2016 -- Catholic Health Initiatives (CHI) expanded its relationship with Allscripts (MDRX) to drive enhanced patient engagement and enable clinicians to monitor care-plan compliance remotely.
CHI, one of the nation’s largest nonprofit health systems, will expand its use of the FollowMyHealth patient engagement platform from the ambulatory to acute care settings, replacing one of its legacy acute patient portals, to provide patients a single portal experience. CHI implemented FollowMyHealth across a number of ambulatory settings in 2015. With its expanded use of FollowMyHealth, CHI will build upon the organization’s success in achieving high patient-adoption rates.
“Allscripts FollowMyHealth was immediately successful for our organization, with 46,000 patients enrolling in a just few months,” Dr. Samuel Alfano, Catholic Health Initiatives Regional Chief Medical Informatics Officer, said. “Our goal is to provide our patients with an easy way to interact with their healthcare providers and personal health information.”
CHI will also implement FollowMyHealth Achieve, which enables providers to involve patients directly in the ongoing management of their care. With FollowMyHealth Achieve, clinicians enter orders in the Allscripts TouchWorks® electronic health record (EHR), which are then available to patients at home or on their mobile device through the portal. Home-based wireless technologies capture readings and results, and push the information to the EHR. The care team is automatically notified if the patient is noncompliant or if individual results exceed clinician-established parameters. FollowMyHealth Achieve enables providers to monitor conditions remotely and, more importantly, initiate interventions as needed to influence behavior and impact outcomes.
"Patient engagement is critically important in today’s healthcare environment, and is a keystone in CHI’s efforts to deliver quality care and improve outcomes," said Allscripts Senior Vice President and General Manager of Population Health, Martha Thorne. "CHI will continue to build on our partnership’s success in engaging patients in their own health."
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2016 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact: Investors: Seth Frank 312-506-1213 [email protected] Media: Concetta DiFranco 312-447-2466 [email protected]


RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



